SIGILON THERAPEUTICS INC (SGTX)
US82657L2060 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.374M -5.55% | 9.599M -28.23% | 12.944M 34.85% | 16.082M 24.24% | 16.32M 1.48% | 16.32M | 13.26M -18.75% | 13.26M | 13.26M | |
| EBITDA YoY % growth | -51.788M -19.22% | -74.518M -43.89% | -42.402M 43.10% | -33.274M 21.53% | -35.967M -8.09% | -35.967M | N/A | N/A | N/A | |
| EBIT YoY % growth | -52.642M -19.32% | -75.636M -43.68% | -43.666M 42.27% | -33.077M 24.25% | -37.479M -13.31% | -38.027M -1.46% | -44.268M -16.41% | -45.084M -1.84% | -45.798M -1.58% | |
| Operating Margin | -393.61% | -787.96% | -337.35% | -205.67% | -229.65% | -233.01% | -333.85% | -340.00% | -345.38% | |
| EPS YoY % growth | N/A | -2.43 95.31% | -7.11 -192.59% | -9.56 -34.47% | -13.12 -37.23% | -11.37 13.36% | -0.94 91.75% | -0.94 | -0.47 50.00% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -4.81 -993.02% | -3.35 4.54% | -3.40 -24.60% |
| Revenue Q2Q % growth | 4.335M 50.36% | 4.335M 1.95% | 4.335M 63.96% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.188M 41.66% | -8.418M 0.06% | -8.647M -11.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -2.99 -595.35% | -3.01 | 0.02 | 0.52% |
| Q4 2022 Q2Q % growth | -2.73 -396.36% | -5.01 | 2.28 | 45.53% |
| Q3 2022 Q2Q % growth | -3.51 -457.14% | -5.64 | 2.13 | 37.72% |
| Q2 2022 Q2Q % growth | -0.44 32.31% | -0.44 | 0.00 | 0.26% |
| Q1 2022 Q2Q % growth | -0.43 28.33% | -0.34 | -0.09 | -26.79% |
| Q4 2021 Q2Q % growth | -0.55 52.17% | -0.57 | 0.02 | 4.05% |
| Q3 2021 Q2Q % growth | -0.63 | -0.67 | 0.04 | 6.13% |
| Q2 2021 Q2Q % growth | -0.65 | -0.64 | -0.01 | -1.55% |
| Q1 2021 Q2Q % growth | -0.60 | -0.61 | 0.01 | 0.86% |
| Q4 2020 Q2Q % growth | -1.15 | -1.40 | 0.25 | 17.70% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 4.858M 53.49% | 3.162M | 1.696M | 53.64% |
| Q4 2022 Q2Q % growth | 2.644M 32.86% | 2.72M | -76K | -2.79% |
| Q3 2022 Q2Q % growth | 4.252M 118.39% | 2.55M | 1.702M | 66.75% |
| Q2 2022 Q2Q % growth | 2.883M 6.62% | 2.55M | 333K | 13.06% |
| Q1 2022 Q2Q % growth | 3.165M 7.00% | 2.04M | 1.125M | 55.15% |
| Q4 2021 Q2Q % growth | 1.99M -47.02% | 2.72M | -730K | -26.84% |
| Q3 2021 Q2Q % growth | 1.947M -53.64% | 2.958M | -1.011M | -34.18% |
| Q2 2021 Q2Q % growth | 2.704M -50.08% | 3.162M | -458K | -14.48% |
| Q1 2021 Q2Q % growth | 2.958M -14.66% | 3.57M | -612K | -17.14% |
| Q4 2020 Q2Q % growth | 3.756M 21.16% | 3.264M | 492K | 15.07% |
| Q3 2020 Q2Q % growth | 4.2M 0.72% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.21% | -1950% | -1057.2% | -1057.2% |
| Revenue | 0% | 37.1% | 27.67% | 27.67% |